A detailed history of Kovitz Investment Group Partners, LLC transactions in Alpha Tau Medical Ltd. stock. As of the latest transaction made, Kovitz Investment Group Partners, LLC holds 32,265 shares of DRTS stock, worth $99,376. This represents 0.0% of its overall portfolio holdings.

Number of Shares
32,265
Previous 32,265 -0.0%
Holding current value
$99,376
Previous $81,000 6.17%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$2.05 - $2.9 $5,225 - $7,392
2,549 Added 8.58%
32,265 $81,000
Q1 2024

May 14, 2024

BUY
$2.84 - $3.35 $84,393 - $99,548
29,716 New
29,716 $87,000

Others Institutions Holding DRTS

About Alpha Tau Medical Ltd.


  • Ticker DRTS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 69,011,296
  • Market Cap $213M
  • Description
  • Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast canc...
More about DRTS
Track This Portfolio

Track Kovitz Investment Group Partners, LLC Portfolio

Follow Kovitz Investment Group Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kovitz Investment Group Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kovitz Investment Group Partners, LLC with notifications on news.